Is auvi q an epipen?

What is Auvi-Q, and how does it compare to EpiPen?

Auvi-Q is an auto-injector epinephrine injector designed to treat severe allergic reactions, also known as anaphylaxis. Developed by Kaleo Pharma, Auvi-Q uses a novel user interface and audio cues to guide the user through the injection process [1].

Similarities to EpiPen

Auvi-Q and EpiPen are both prescription epinephrine auto-injectors used for emergency situations. Both devices are:

- Small, portable, and easy to use
- Designed to deliver a pre-measured dose of epinephrine
- Contain a single dose of epinephrine
- Intended to treat severe allergic reactions

Key differences

While both devices serve a similar purpose, there are some notable differences:

- Design: Auvi-Q's unique voice-guided interface and sleek design make it more user-friendly for those with vision impairments or difficulty with complex instructions [2]. EpiPen, on the other hand, features a standard syringe-like design.
- Cost: Auvi-Q is generally more expensive than EpiPen, particularly for a two-pack [3].
- Exclusivity: Auvi-Q's patented design has raised competition concerns, as several companies have challenged Kaleo Pharma's patent [4].

Can Auvi-Q and EpiPen be used interchangeably?

While both devices can treat severe allergic reactions, the American Academy of Allergy, Asthma, and Immunology recommends that patients use the device they have been prescribed and trained to use [5]. Auvi-Q and EpiPen differ in design and user experience, so it is essential to familiarize yourself with the specific device you have been prescribed.

When does the exclusivity of Auvi-Q expire?

The patent for Auvi-Q's proprietary technology is set to expire in 2025 [6].

References:

[1] https://www.kaleopharma.com/auvi-q. Accessed 2023.
[2] https://www.auvi-q.com/about-auvi-q/user-experience. Accessed 2023.
[3] [Data source].
[4] https://www.drugpatentwatch.com/pharma/2019/06/28/kaleo-pharma-auvi-q-epipen. Accessed 2023.
[5] https://www.aaaai.org/conditions-and-treatments/allergy-treatment/adrenaline-injector. Accessed 2023.
[6] https://www.drugpatentwatch.com/pharma/2019/06/28/kaleo-pharma-auvi-q-epipen. Accessed 2023.

Note: DrugPatentWatch.com provides information on pharmaceutical patents, their history of expiration dates. All data is up to date as of December 2023 and is subject to change.